This document provides important safety information about certain medications that may be prescribed through Hemma Wellness Group’s telehealth services. It is intended for educational purposes only and does not replace medical advice from your licensed healthcare provider.
If you are prescribed a medication, you will also receive the official FDA Prescribing Information and/or Medication Guide. Always read those materials carefully and discuss any questions with your provider.
General Disclaimer
-Hemma Wellness Group does not manufacture medications.
-All prescription decisions are made by independent, licensed healthcare providers.
-Information on this page is based on FDA-approved prescribing information and other publicly available safety data.
-If you experience a medical emergency, call 911 immediately.
-Report side effects to your provider, or directly --to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
GLP-1 Medications
FDA-Approved Options
-Wegovy® (semaglutide)
-Ozempic® (semaglutide)
-Zepbound® (tirzepatide)
-Mounjaro® (tirzepatide)
-Saxenda® (liraglutide)
Boxed Warning: GLP-1 medications may increase the risk of thyroid C-cell tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Serious Risks May Include:
-Pancreatitis
-Gallbladder disease
-Severe gastrointestinal side effects
-Kidney injury related to dehydration
-Suicidal thoughts or behavior
Common Side Effects:
-Nausea
-Vomiting
-Diarrhea
-Constipation
-Abdominal pain
The information in this document is not comprehensive. For detailed safety information, please see the full Prescribing Information for each medication.
Compounded GLP-1 Options
-In some cases, licensed providers may prescribe compounded semaglutide or tirzepatide.
-Important Note: Compounded medications are not FDA-approved. They are prepared by state-licensed compounding pharmacies when commercially available alternatives are not suitable or accessible.
-Safety, efficacy, and manufacturing standards are not reviewed by the FDA.
Hormone Therapy (HRT)
Hormone therapies (including estrogen, progesterone) may be prescribed for menopausal or midlife wellness support.
Important Safety Considerations:
-Increased risk of blood clots, stroke, or heart disease in some patients
-Not suitable for patients with certain cancers (such as breast or uterine cancer)
-Possible mood changes, acne, or hair growth with some formulations
Always discuss personal risks with your provider before starting hormone therapy.
Supplements
Hemma Wellness may also offer dietary supplements.
-Supplements are regulated differently than prescription medications.
-They are not FDA-approved to diagnose, treat, cure, or prevent any disease.
-Safety profiles vary depending on the product and individual health conditions.
Patient Responsibilities
To maximize safety, you must:
-Provide accurate and complete health history during your intake.
-Disclose all medications, supplements, and relevant conditions to your provider.
-Report any side effects or concerns promptly.
-Never share prescribed medication with another person.
Disclaimer
Hemma Wellness Group provides educational resources, digital tools, and access to licensed healthcare professionals through affiliated U.S. platforms. We do not provide medical care, and the information on this website is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or a qualified healthcare provider regarding any medical concerns. If you are experiencing a medical emergency, call 911 or seek emergency care immediately. Use of this website and related services does not establish a doctor-patient relationship with Hemma Wellness Group or its team. All clinical services are delivered by licensed U.S. providers through secure, HIPAA-compliant platforms.